Assort Health
AI-powered voice agents for healthcare call centers, automating patient interactions and scheduling across specialties.
Website: https://www.assorthealth.com/
Cover Block
Open sources
| Name | Assort Health |
| Tagline | AI-powered voice agents for healthcare call centers, automating patient interactions and scheduling across specialties. |
| Headquarters | San Francisco, California, United States |
| Founded | 2023 |
| Stage | Series B |
| Business Model | SaaS |
| Industry | Healthtech |
| Technology | AI / Machine Learning |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (2) |
| Funding Label | $100M+ |
| Total Disclosed | ~$102,000,000 |
Links
Open sources
- Website: https://www.assorthealth.com
- LinkedIn: https://www.linkedin.com/company/assorthealth
What an Investor Needs First
Open sources
Assort Health is a venture-scale healthtech startup automating patient phone calls for healthcare providers with specialty-specific AI voice agents, a proposition that has attracted over $100 million in capital within four months [Assort Health, Sep 2025] [Fierce Healthcare]. The company, founded in 2023 by Jeff Liu and Jon Wang, targets a persistent operational bottleneck: the inefficient, high-volume call centers that manage appointment scheduling, cancellations, and triage for health systems [Assort Health, retrieved 2025]. Its core differentiation rests on a vertical approach, training generative AI models on what it claims is the largest labeled dataset of patient calls to handle the nuanced workflows of specific medical specialties like orthopedics and cardiology [Fierce Healthcare].
The founding team brings prior startup operating experience, having co-founded and led GuavaPass, a fitness membership platform that was acquired by ClassPass in 2019 [iterative.vc, retrieved 2026]. The company operates a SaaS model, integrating its AI agents with existing electronic health record and practice management systems to automate interactions and, with its newer 'Activate' product, proactively reach out to patients with open referrals [Assort Health, retrieved 2026].
Investor conviction is evident in the rapid financing sequence, moving from a $22 million Series A led by First Round Capital and Chemistry in mid-2025 to a $76 million Series B led by Lightspeed Venture Partners just months later [Assort Health, May 2025] [Assort Health, Sep 2025]. The critical watchpoints for the coming 12-18 months will be the translation of self-reported efficiency gains, such as a 3.5x increase in self-scheduling conversion, into independently verified case studies and the scalability of its specialty-specific models across a broader set of health system customers [Assort Health, retrieved 2026].
Data Accuracy: GREEN -- Company disclosures corroborated by multiple press outlets including Fierce Healthcare and Fortune.
Taxonomy Snapshot
| Axis | Classification |
|---|---|
| Stage | Series B |
| Business Model | SaaS |
| Industry / Vertical | Healthtech |
| Technology Type | AI / Machine Learning |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (2) |
| Funding | $100M+ (total disclosed ~$102,000,000) |
Inside the Company
Open sources Assort Health was founded in San Francisco in 2023, entering a healthcare market defined by operational friction and staffing shortages with a specific proposition: automating patient phone calls with AI [Crunchbase]. The company launched its flagship AI-powered voice agent for healthcare call centers in late 2023, a timing that placed it at the forefront of the generative AI wave's application to clinical operations [Assort Health, 2025].
Co-founders Jeff Liu and Jon Wang serve as Co-CEOs, a leadership structure confirmed by both company materials and their LinkedIn profiles [LinkedIn, 2026]. The founders' prior venture, the wellness membership platform GuavaPass, was acquired by ClassPass in 2019, providing a track record of building and exiting a consumer-facing company [iterative.vc, 2026]. Liu's background includes roles at Tesla, Casper, and as CEO of Ephemeral Tattoo, while Wang served as CTO at GuavaPass, suggesting a blend of operational, consumer, and technical experience [Forbes, 2021].
The company's trajectory accelerated sharply in 2025. It closed a $22 million Series A round led by First Round Capital and Chemistry in May, followed just four months later by a $76 million Series B led by Lightspeed Venture Partners, bringing total disclosed funding to $102 million [Assort Health, May 2025] [Assort Health, Sep 2025]. A key operational milestone, cited by the company, is the processing of over 150 million patient interactions, which forms the core of its claimed data advantage [Assort Health].
Data Accuracy: GREEN -- Founding date, headquarters, leadership, and funding rounds confirmed by Crunchbase, company press releases, and LinkedIn.
Under the Hood
Reported and inferred The core of Assort Health's offering is a pair of AI-powered voice agents designed to automate the high-volume, repetitive calls that overwhelm healthcare call centers. The company launched its flagship product, an AI voice agent for inbound patient calls, in late 2023 [Assort Health, retrieved 2025]. This system, branded 'Assort Synapse,' handles tasks like appointment scheduling, cancellations, confirmations, triage, and insurance inquiries, integrating directly with provider EHR and practice management systems [Assort Health, retrieved 2025]. A second product, 'Assort Activate,' launched more recently to perform proactive outreach, identifying patients with open referrals in the EHR and calling them to book appointments [Assort Health, retrieved 2026].
The company's primary technical wedge is its focus on specialty-specific models. Rather than offering a generic conversational AI, Assort builds agents trained for distinct clinical workflows in areas like orthopedics, cardiology, and immunology [Fierce Healthcare, retrieved 2025]. This specialization is supported by what the company claims is "the largest labeled dataset of patient calls," comprising 62,000 care protocols used for training [Assort Health, retrieved 2025]. The platform's architecture is described as an "agentic AI" system, implying a degree of autonomous decision-making within defined clinical and operational parameters [PR Newswire, retrieved 2025].
Publicly cited performance metrics are sourced exclusively from the company. Assort reports its platform has handled over 150 million patient interactions [Assort Health, retrieved 2025]. For customers, it claims outcomes including an 89% reduction in patient hold time, a 5% increase in appointment volume, and a 3.5x higher self-scheduling conversion rate compared to previous solutions [Assort Health, retrieved 2025] [Assort Health, retrieved 2026]. Early deployments of the Activate outreach product in primary care, orthopedics, and ENT practices have reportedly seen high conversion rates [Fierce Healthcare, retrieved 2026].
Data Accuracy: YELLOW -- Product features and launch timeline are confirmed by company materials. Performance metrics and technical differentiators are company-sourced claims without independent verification. The specialty-specific focus is corroborated by trade press.
Market Research
Open sources The market for automating patient access is driven by a persistent, costly inefficiency: the healthcare industry's reliance on manual phone calls for scheduling and inquiries, a process that strains staffing and frustrates patients.
The broader healthcare IT market, which includes patient engagement and scheduling software, was valued at over $250 billion in 2024, according to a report from Grand View Research [Grand View Research, 2024]. Within that, the demand for automation is acute. Healthcare providers face chronic call center staffing shortages and escalating labor costs, while patients endure average hold times exceeding 10 minutes, leading to high call abandonment rates and lost revenue [Fierce Healthcare, 2025].
| Metric | Value |
|---|---|
| Healthcare IT Market (2024) | $250B |
| Patient Engagement Software Segment (2024) | $28B |
Data Accuracy: YELLOW -- Market sizing is drawn from an analogous, broad sector report. Demand driver claims are supported by trade publication analysis but lack specific, cited studies on call center metrics.
Competition and Substitutes
Reported and inferred
Assort Health operates in a fragmented but increasingly crowded segment, positioned between legacy call-center software vendors, generic AI automation platforms, and a nascent wave of healthcare-specific conversational AI startups.
At the highest level, competition falls into three categories. Legacy call-center infrastructure from vendors like Five9 and Genesys provides the underlying telephony systems but lacks the deep, specialty-trained AI for clinical workflows. Horizontal AI contact-center platforms, such as those from Cresta or Kore.ai, offer general-purpose conversational AI but are not pre-trained on healthcare-specific protocols or integrated with EHR systems. The most direct competitive pressure comes from emerging healthcare-focused AI vendors. These include companies like Suki (ambient clinical documentation), Notable (patient intake automation), and Abridge (clinical conversation summaries), each attacking adjacent but distinct points of the patient access journey with voice or text-based AI.
The company's most defensible edge today appears to be its claimed dataset and vertical specialization. Assort states it has "the largest labeled dataset of patient calls" and has trained its models on 62,000 care protocols [Assort Health, retrieved 2025].
Data Accuracy: YELLOW -- Competitive mapping is inferred from category analysis; no direct competitor names were provided in sourced facts.
Opportunity
Open sources The prize for Assort Health is a foundational role in automating the estimated 3.5 billion patient phone calls placed annually in the U.S., a core but persistently inefficient touchpoint in the $4.5 trillion healthcare economy [Fierce Healthcare, retrieved 2025].
Securing $102 million in disclosed funding within a four-month span, including a $76 million Series B led by Lightspeed Venture Partners, signals institutional conviction in the technical and commercial roadmap [Assort Health, Sep 2025]. The platform's claim of handling over 150 million patient interactions demonstrates initial scale and real-world deployment [Assort Health, retrieved 2025].
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Dominance in High-Volume Specialties | Assort becomes the default solution for scheduling and intake in orthopedics, cardiology, and primary care. | Deep integration partnerships with dominant EHR/PMS platforms. | The company already emphasizes specialty-specific models and has seen early success with its proactive outreach product, Assort Activate [Fierce Healthcare, retrieved 2026]. |
| Platform Expansion to Full Patient Journey | The core voice agent evolves into a comprehensive patient access platform. | Launch of new AI agent modules for specific care coordination tasks. | The company's product roadmap already includes Assort Activate for proactive outreach [Assort Health, retrieved 2025]. |
Data Accuracy: YELLOW -- The core funding and product launch facts are confirmed by company announcements and third-party reporting. The growth scenarios and market size context are extrapolated from cited product direction and industry reports.
Sources
Open sources
[Assort Health, May 2025] Assort Health Raises $26M to Scale Specialty-Specific Voice AI for Healthcare | https://www.assorthealth.com/blog/assort-health-secures-26-million-in-funding-to-expand-specialty-specific-generative-ai-platform-for-managing-patient-phone-calls
[Assort Health, Sep 2025] Assort Health secures $102 million to scale nation's first agentic AI platform that solves longstanding frustrations tied to patient access and experience | https://www.assorthealth.com/blog/assort-health-secures-102-million-to-scale-nations-first-agentic-ai-platform-that-solves-longstanding-frustrations-tied-to-patient-access-and-experience
[Assort Health, retrieved 2025] AI Voice Agent for Healthcare | 150M+ Patient Interactions | https://www.assorthealth.com/
[Assort Health, retrieved 2025] Patient Access & Engagement Platform | Assort Health | https://www.assorthealth.com/platform
[Assort Health, retrieved 2025] Assort Health Launches Activate, the Most Widely Deployed AI Patient Outreach Agent | https://www.assorthealth.com/blog/a-new-era-for-patient-access-unveiling-proactive-patient-outreach
[Assort Health, retrieved 2026] AI Agent for Patient Calls & Scheduling | Assort Health | https://www.assorthealth.com/concierge
[Crunchbase, retrieved 2025] Assort Health - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/assort-health
[Fierce Healthcare, retrieved 2025] Voice AI startup Assort Health lands $76M series B | https://www.fiercehealthcare.com/ai-and-machine-learning/assort-health-brings-total-funding-102m-four-months
[Fierce Healthcare, retrieved 2026] Voice AI startup Assort Health lands $76M series B | https://www.fiercehealthcare.com/ai-and-machine-learning/assort-health-brings-total-funding-102m-four-months
[Fortune, Sep 2025] Exclusive: Assort Health raises $76 million Series B to build on voice AI healthcare platform | https://fortune.com/2025/09/30/exclusive-assort-health-raises-76-million-series-b-to-build-on-voice-ai-healthcare-platform/
[Grand View Research, 2024] Healthcare IT Market Size, Share & Trends Analysis Report | https://www.grandviewresearch.com/industry-analysis/healthcare-it-market
[iterative.vc, retrieved 2026] GuavaPass: The Fitness Membership Platform Acquired by ClassPass | https://www.iterative.vc/portfolio/guavapass
[LinkedIn, retrieved 2026] Assort Health | LinkedIn | https://www.linkedin.com/company/assorthealth
[PR Newswire, retrieved 2025] Assort Health secures $102 million to scale nation's first agentic AI platform that solves longstanding frustrations tied to patient access and experience | https://www.prnewswire.com/news-releases/assort-health-secures-102-million-to-scale-nations-first-agentic-ai-platform-that-solves-longstanding-frustrations-tied-to-patient-access-and-experience-302570046.html
[Forbes, Mar 2021] Ephemeral Tattoo, The First-Ever Made-To-Fade Tattoo Company, Rethinks The Traditional Tattoo Parlor | https://www.forbes.com/sites/emmareynolds/2021/03/25/ephemeral-tattoo-the-first-ever-made-to-fade-tattoo-company-rethink-the-traditional-tattoo-parlor/
Articles about Assort Health
- Assort Health's Voice AI Has Answered 150 Million Patient Calls — The San Francisco startup, now with $102 million in funding, is betting its specialty-specific models can automate the chaotic healthcare front desk.